Cleared Traditional

K882955 - SUPERMON NEONATAL NON-INVASIVE BLOOD PR...

K882955 is an FDA 510(k) clearance for SUPERMON NEONATAL NON-INVASIVE BLOOD PR..., manufactured by Kontron Instruments, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 561-day FDA review.

K882955 · Kontron Instruments, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
561d
Days
Class 2
Risk

K882955 is an FDA 510(k) clearance for the SUPERMON NEONATAL NON-INVASIVE BLOOD PRESS. 7283. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Kontron Instruments, Inc. (Everett, US). The FDA issued a Cleared decision on January 26, 1990 after a review of 561 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Kontron Instruments, Inc. devices

FDA 510(k) Submission Details - K882955

510(k) Number K882955 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 1988
Decision Date January 26, 1990
Days to Decision 561 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
436d slower than avg
Panel avg: 125d · This submission: 561d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 552
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K882955.
BIOCHEM 6100 NON-INVASIVE MONITOR
K903222 · Biochem International, Inc. · Sep 1990
FUKUDA DENSHI MODEL HJ-310
K901889 · Fukuda Denshi USA, Inc. · Jul 1990
ESCORT NON-INVASIVE BLOOD PRESSURE OPTION
K896958 · Medical Data Electronics · Mar 1990
A&D AUTOMATIC DIGITAL BLOOD PRESSURE METER 2510/20
K895428 · A&D Engineering, Inc. · Nov 1989
A&D AUTOMATIC DIGITAL BLOOD PRESSURE METER 2650
K895429 · A&D Engineering, Inc. · Nov 1989
NON-INVASIVE BLOOD PRESSURE MODULE
K894945 · Marquette Electronics, Inc. · Oct 1989